Literature DB >> 1582984

Autologous bone marrow transplantation for multiple myeloma.

S Jagannath1, B Barlogie.   

Abstract

Intensive cytotoxic chemotherapy is capable of more marked tumor cytoreduction including true complete remissions in multiple myeloma. Use of autologous marrow and blood stem cells as well as growth factors has reduced the risk of infection and severe extramedullary toxicities.

Entities:  

Mesh：

Year:  1992        PMID： 1582984

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  2 in total

1.  Monoclonal gammopathy of unknown significance in a bone marrow donor.

Authors:  S O Peters; M Stockschläder; W Zeller; K Mross; M Dürken; W Krüger; A R Zander
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

2.  High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

Authors:  Mauricio Pineda-Roman; Bart Barlogie; Elias Anaissie; Maurizio Zangari; Vanessa Bolejack; Frits van Rhee; Guido Tricot; John Crowley
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.